US 2024/0199639 A1Published application

Pretomanid amorphous form

AssigneeGlobal Alliance for TB Drug Development

InventorsRajneesh TANEJA, Poonam G. PANDE

Life of this patent

Estimating the term…

Abstract

The present invention relates to pretomanid in amorphous form. The invention also relates to method of using the same, such as in a method of treating a mycobacterial infection.

Claims33

Dependent claims

An amorphous form of pretomanid.

Dependencies are inferred from the claim text.

Facts

Application: 18/274,483Filed 1 Feb 2022
Priority: 1 Feb 2021
Published: 20 Jun 2024
Term ends: Not estimatedThe source records don’t support an estimate.

Classification18 codes

C07D 498/04
In which the condensed system contains two hetero rings: ortho-condensed systems
A61K 9/0053
Galenical forms characterised by the site of application: mouth and digestive tract, i.e. intraoral and peroral administration
A61K 9/10
Medicinal preparations characterised by special physical form: dispersions; Emulsions
A61K 9/146
Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried,…: with…

Family

Application63/144,059Us provisional application · filed 1 Feb 2021
US 2024/0199639 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results